| Categories |
Description |
Criteria |
Excellence in Advanced Materials Packaging
|
Recognizes innovative packaging materials developed to improve product protection, performance, or functionality in pharmaceutical packaging.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Anti-Counterfeit Packaging
|
Recognizes packaging solutions designed to protect pharmaceutical products against counterfeiting, tampering, and unauthorized distribution.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Automation & Machinery Packaging
|
Recognizes innovations in automated packaging equipment that improve speed, accuracy, safety, and operational efficiency.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Biologics
|
Recognizes packaging designed to protect biologics, vaccines, and other temperature-sensitive drugs by maintaining required temperatures and ensuring product stability during storage and transport.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented or launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Child-Resistant & Accessible Packaging
|
Recognizes packaging that prevents accidental access by children while remaining accessible to seniors and individuals with limited strength, mobility, or vision.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Drug Delivery Packaging
|
Recognizes packaging that enhances the delivery, administration, or dosage accuracy of pharmaceutical products, improving treatment outcomes and patient compliance.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Packaging Design
|
Primary Packaging Design
- Recognizes excellence in pharma-led or pharma-owned primary packaging design that ensures drug product protection, safety, integrity, and patient-friendly use, while meeting regulatory and quality requirements.
Secondary Packaging Design
- Recognizes pharma-driven secondary packaging design that enhances protection of the primary pack while delivering clear communication, tamper evidence, serialization readiness, and improved patient accessibility..
Tertiary Packaging Design
- Recognizes efficient and innovative tertiary packaging approaches led by pharma companies that safeguard products throughout the supply chain while optimizing logistics, cost, sustainability, and operational performance.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Packaging R&D Collaboration
|
Recognizes collaborative research and development efforts between pharmaceutical companies and ecosystem partners that resulted in innovative pharmaceutical packaging solutions, technologies, or formats.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The R&D initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Mandatory collaboration requirement:
- This category is open only to collaborative R&D initiatives involving a pharmaceutical company and one or more ecosystem partners engaged in packaging materials, technology, design, engineering, testing, validation, or manufacturing.
- Collaborations involving more than one pharmaceutical company are also permitted, provided the initiative demonstrates clear relevance to pharmaceutical packaging R&D.
- Solo or single entity initiatives are not eligible.
- Concept-only proposals are not accepted.
|
Excellence in Patient-Centric Packaging
|
Recognizes packaging solutions designed to improve usability, safety, and clarity for patients or healthcare providers.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024 to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Supply Chain Innovation
|
Recognizes collaborative initiatives that enhanced pharmaceutical packaging supply chain efficiency, logistics performance, or packaging operations through joint efforts between pharma companies and ecosystem partners.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- This category is open only to joint projects executed between a pharmaceutical company and one or more ecosystem partners involved in pharmaceutical packaging, supply‑chain operations, logistics, materials, technology, or machinery.
- The pharmaceutical company may be either the Participating Entity (Lead Applicant) or a Collaborating Partner Entity.
- Solo or single entity initiatives are not eligible.
- Concept-only proposals are not accepted.
|
Excellence in Sustainable Pharma Packaging
|
Recognizes pharmaceutical companies that have successfully implemented packaging solutions that significantly reduce environmental impact.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence in Traceability Systems
|
Recognizes packaging technologies and digital systems that enable pharmaceutical products to be tracked and verified across the entire supply chain, ensuring transparency, compliance, and product security.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The initiative must have been implemented and launched between April 01, 2024, to March 31, 2026, in the Indian market or have a significant portion executed during this period. However, the product nominated` in relation to the initiative may have been launched prior to the eligibility period.
- If the initiative was launched before the defined period, the participant must clearly highlight the innovation or impact achieved during the eligibility period.
- Concept-only proposals are not accepted.
|
Excellence Pilot Innovation Award
|
Recognizes early-stage packaging innovations validated through pilots or trials.
|
- The participating entity must be registered in India with at least two years of operational presence as of March 31, 2026, and hold a valid GST/Incorporation or valid registration certificate.
- The innovation must be early-stage and validated through at least one of the following:
- Pilot implementation
- Trial run
- Proof-of-concept testing
- Laboratory or simulated validation
- Controlled field evaluation
- The validation, pilot, or trial must have been conducted between April 01, 2024, and March 31, 2026.
- The innovation must demonstrate clear applicability or relevance to pharmaceutical packaging, even if not yet commercially deployed.
- Fully commercialized, mass-market solutions are not eligible for this category.
- Concept-only ideas without testing, validation, or trial results are not eligible.
|
Packaging Professional of the Year
|
Packaging Professional of the Year - Above 10 Years of Experience
- Recognizes senior packaging professionals from pharma companies with over 10 years of experience including 1 years with the current organization, such as a Senior Packaging Engineer or Packaging Development Manager, or equivalent roles, who have demonstrated long-term impact through innovation in packaging design, development, technology, operations, or sustainability.
Packaging Professional of the Year - Up to 10 Years of Experience
- Recognizes emerging or mid-career professionals from pharma companies with up to 10 years of experience including 1 years with the current organization, such as a Packaging Engineer or Packaging Technologist, or equivalent roles, who have shown strong innovation, problem-solving, and early leadership in packaging design, development, technology, or sustainability.
|
- The nominee must be an employee of a pharmaceutical company operating in India.
- The nominee must meet the experience requirement of the category applied for, as of March 31, 2026.
- The nominee must have completed at least one year of continuous service with the current organization.
|